MYLAN $31.87

up +0.33


18/6/2013 04:18 PM  |  NASDAQ : MYL  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 31.87
Trade Time: Jun 18 4:04 PM Eastern Daylight Time
Change: 0.33 (1.05 %)
Prev Close: 31.54
Open: 31.62
Bid: 31.82
Ask: 31.85
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get MYL Trend Analysis - it has outperformed the S&P 500 by 27%

ETF Alternatives



People viewing MYL also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXEI RXELITE 45.2K +4.00%
ALSE ALSERES PHARMACEUTICALS 600.0 +1.00%
ALLP ALLIANCE PHARMACEUTICAL 3.5K +0.82%
KVPBQ K-V PHARMACEUTICAL 1.4K +0.82%
HRDN DC BRANDS INTERNATIONAL INC. C 16.7M +0.67%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
6/3/2013 DIMICK NEIL F Director -19,994 $30.51 -38.35%
6/3/2013 DIMICK NEIL F Director 19,994 $12.96 62.22%
4/1/2013 SHEEHAN JOHN D EVP and CFO -2,474 $28.70 -6.78%
4/1/2013 SHEEHAN JOHN D EVP and CFO -9,428 $28.70 -17.36%
3/18/2013 KORMAN HARRY Chief Operating Officer 22,908 $17.46 19.51%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (MYL), click here.
View All

MYL Stock Analysis

  1. Simcere Ties Up with Bristol-Myers - Analyst Blog

    (BMY,SCR,ACT,MYL )
    Simcere Pharmaceutical Group recently announced that it has entered into a strategic agreement with Bristol-Myers Squibb Company (BMY).

  2. Label Expansion for Astellas Drug - Analyst Blog

    (ALPMY,RDY,MYL,ACT )
    Astellas Pharma Inc. announced the approval of Prograf in Japan for an additional indication
  3.

    $2.15B Settlement for Pfizer's Protonix - Analyst Blog

    (PFE,TEVA,MYL,TKPYY )
    While Teva will make a payment of $1.6 billion, Sun Pharma will pay the remaining $550 million.

  4. Actavis-Medicines360 Ink Partnership - Analyst Blog

    (ACT,SNTS,WCRX,MYL )
    Actavis gained commercial rights in the US and Canada to the LNG20 intrauterine device.

  5. Valeant Eyes Bausch & Lomb

    (VRX,AGN,FRX,MYL, )
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was buying Bausch & Lomb for $8.7 billion making it a global leader in eye care. What does this deal mean for Valeant investors? I'll have a look.
  6.

    A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    (ACT,WCRX,VRX,MYL )
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
Free Reports
  1.

    Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
  2.

    Stock Ideas From Warren Buffett

    Access Coattail Investor’s latest free report and get two investing ideas from Warren Buffett himself!
  3.

    21-page Book on Learning to Trade Options on Futures!

    Not too complex. Not too basic. Just enough information to help you ask the right questions so you can start using these markets.
Marketplace
Trading Center